Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release
Fennec PharmaFennec Pharma(US:FENC) ZACKS·2026-03-02 16:00

Core Viewpoint - The market anticipates Adherex Technologies Inc. (FENC) will report a year-over-year increase in earnings driven by higher revenues in its upcoming earnings report for the quarter ended December 2025 [1] Earnings Expectations - The consensus estimate for quarterly earnings is $0.03 per share, reflecting a year-over-year increase of +150% [3] - Expected revenues are $14.97 million, which is an increase of 88.8% compared to the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 403.57% higher in the last 30 days, indicating a significant reassessment by analysts [4] - The Most Accurate Estimate for Adherex Technologies is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +140.00% [12] Earnings Surprise Prediction - A positive Earnings ESP reading suggests a likely earnings beat, especially when combined with a Zacks Rank of 1 (Strong Buy), 2 (Buy), or 3 (Hold) [10] - Adherex Technologies currently holds a Zacks Rank of 3, indicating a potential to beat the consensus EPS estimate [12] Historical Performance - In the last reported quarter, Adherex Technologies was expected to post a loss of $0.08 per share but instead reported a loss of -$0.02, resulting in a surprise of +75.00% [13] - Over the past four quarters, the company has exceeded consensus EPS estimates two times [14] Conclusion - Adherex Technologies is positioned as a compelling candidate for an earnings beat, but investors should consider additional factors before making investment decisions [17]

Fennec Pharma-Adherex Technologies Inc. (FENC) Earnings Expected to Grow: What to Know Ahead of Q4 Release - Reportify